After Covaxin, Covishield and Sputnik V, a fourth vaccine, DNA-based vaccine ZyCov-D is likely to be in use from next month in Bengal. The Union health ministry assured the state on Wednesday that it...

  The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum Institute of India (SII), as the jab has not yet been approve...

An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain cond...

Drug firm Cadila Healthcare on Tuesday said it has received permission from the Indian drug regulator for conducting phase III trials for its two-dose COVID-19 vaccine ZyCoV-D. The company has alread...

India has approved a DNA vaccine against Covid-19 developed by the Ahmedabad-based pharmaceutical company Zydus Cadila, the country’s second homegrown vaccine against the infection and the first...

First the good news – and then a host of qualifications. India’s vaccination drive’s been a jerky stop-and-start affair but it’s closer to its targets than might have been expe...

Shares of Panacea Biotec on Monday closed with gains of over 5 per cent after the company announced it has received a manufacturing licence for the Sputnik V vaccine. Panacea received the manufacturi...

Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Drug Controller General of India (DCGI) for its COVID-19 vaccine ZyCoV-D. The company said it has conducted...

India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sourc...

Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in the treatment of moderate to se...